Intracellular antimicrobial activity in the absence of interferon-γ: Effect of interleukin-12 in experimental visceral Leishmaniasis in interferon-γ gene-disrupted mice

Journal of Experimental Medicine

Volumn 185, Issue 7, 1997, Pages 1231-1239

  Taylor, Alice P ^a   Murray, Henry W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE DISRUPTION; GRANULOMATOSIS; IMMUNOGENETICS; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

ANIMALS; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; GRANULOMA; GUANIDINES; INTERFERON TYPE II; INTERLEUKIN-12; LEISHMANIASIS, VISCERAL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030895747     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.7.1231     Document Type: Article

References (45)

1. Squires, K.E., R.D. Schreiber, M.J. McElrath, B.Y. Rubin, S.L. Anderson, and H.W. Murray. 1989. Experimental visceral leishmaniasis: role of endogenous IFN-γ in host defense and tissue granulomatous response. J. Immunol. 143:4244-4249.
2. Murray, H.W. 1990. Effect of continuous administration of interferon-γ in experimental visceral leishmaniasis. J. Infect. Dis. 161:992-994.
3. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science (Wash. DC). 159:1739-1742.
4. Graham, M.B., D.K. Dalton, D. Giltinan, V.L. Braciale, T.A. Stewart, and T.J. Braciale. 1993. Response to influenza infection in mice with a targeted disruption in the interferon-γ gene. J. Exp. Med. 178:1725-1732.
5. Cooper, A.M., D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:2243-2247.
6. Wang, Z., S. Zheng, D. Corry, D.K. Dalton, R.A. Seder, S.L. Reiner, and R.M. Locksley. 1994. Interferon-γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA. 91:12932-12936.
7. + effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367-1371.
8. Amiri, P., M. Haak-Frendscho, K. Robbins, J.H. McKerrow, T. Stewart, and P. Jardieu. 1994. Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon-γ knockout mice. J. Exp. Med. 180:43-51.
9. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
10. Murray, H.W., and J. Hariprashad. 1995. Interleukin-12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181: 387-391.
11. Murray, H.W., J.J. Stern, K. Welte, B.Y. Rubin, S.M. Carriero, and C.F. Nathan. 1987. Experimental visceral leishnianiasis: production of interleukin 2 and interferon-γ, tissue immune reaction, and response to treatment with interleukin 2 and interferon-γ. J. Immunol. 138:2290-2297.
12. Murray, H.W., J.S. Cervia, J. Hariprashad, A.P. Taylor, M.Y. Stoeckle, and H. Hockman. 1995. Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis. J. Clin. Invest. 95:1183-1192.
13. Miralles, G.D., M.Y. Stoeckle, D.F. McDermott, F.D. Finkelman, and H.W. Murray. 1994. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62:1058-1063.
14. Stenger, S., H. Thuring, M. Rolinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
15. Tumang, M.C.T., C. Keogh, L.L. Moldawer, D.C. Helfgott, R. Teitelbaum, J. Hariprashad, and H.W. Murray. 1994. Role and effect of TNF-α in experimental visceral leishmaniasis. J. Immunol. 153:768-775.
16. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B.R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuherculosis. Infect. Immun. 63:730-740.
17. McElrath, M.J., H.W. Murray, and Z.A. Cohn. 1988. Dynamics of granuloma fomiation in experimental visceral leishmaniasis. J. Exp. Med. 167:1927-1937.
18. Murray, H.W., G.D. Miralles, M.Y. Stoeckle, and D.F. McDermott. 1993. Role and effect of IL-2 in experimental visceral leishmaniasis. J. Immunol. 151:929-938.
19. Gazzinelli, R., S. Hieny, T.A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin-12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA. 90:6115-6119.
20. Wynn, T.A., I. Eltoum, I. Oswald, A.W. Cheever, and A. Sher. 1994. Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551-1561.
21. + T cells to enhance priming for interferon-γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
22. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridges innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-162.
23. Morris, S.C., K.B. Madden, J.J. Adamovicz, W.C. Gause, B.R. Hubbard, M.K. Gately, and F.D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047-1056.
24. Brunda, M.J. 1994. Interleukin-12. J. Leuk. Biol. 55:280-288.
25. + natural killer cells stimulated with interleukin-2, interleukin-7, and interleukin-12. Eur. J. Immunol. 23:1831-1838.
26. Liew, F.Y., S. Millott, C. Parkinson, R.M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
27. Green, S.J., M.S. Meltzer, J.B. Hibbs, and C.A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-283.
28. Appelberg, R., A.G. Castro, J. Pedrosa, R.A. Silva, I.M. Orme, and P. Minoprio. 1994. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962-3971.
29. Dumarey, C.H., V. Labrousse, N. Rastogi, B.B. Vargaftig, and M. Bachelet. 1994. Selective Mycobacterium avium - induced production of nitric oxide by human monocyte-derived macrophages. J. Leuk. Biol. 56:36-40.
30. Roach, T.I., A.F. Kiderlen, and J.M. Blackwell. 1991. Role of inorganic nitrogen oxides and tumor necrosis factor-alpha in killing Leishmania donovani amastigotes in gamma-interferon lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect. Immun. 59:3935-3944.
31. Feng, H., V.L. Popov, and D.H. Walker. 1994. Depletion of gamma interferon and tumor necrosis factor-alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease. Infect. Immun. 62:1952-1960.
32. Murray, H.W., C.W. Juangbhanich, C.F. Nathan, and Z.A. Cohn. 1979. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. J. Exp. Med. 150: 950-964.
33. Nathan, C.F., H.W. Murray, and Z.A. Cohn. 1980. The macrophage as an effector cell. N. Engl. J. Med. 303:622-626.
34. Murray, H.W. 1982. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-independent killing of intracellular Leishmania donovani. J. Immunol. 129: 351-357.
35. Chan, J., Y. Xing, R.S. Magliosso, and B.R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
36. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
37. Nacy, C.A. A.I. Meierovics, M. Belosevic, and S.J. Green. 1991. Tumor necrosis factor-alpha: central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathobiology. 59:182-184.
38. + human T cell clones. Eur. J. Immunol. 19:197-200.
39. Liew, F.Y., C. Parkinson, S. Millott, A. Severn, and M. Carrier. 1990. TNF-α mediates host protection against cutaneous leishmaniasis. Immunology. 69:570-573.
40. Flynn, J.L., M.M. Goldstein, K.J. Triebold, J. Sypek, S. Wolf, and B. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
41. Scharton-Kersten, T.M., T.A. Wynn, E.Y. Denkers, S. Bala, E. Grunvald, S. Heiny, R.T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045-4054.
42. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. Emile, M. Newport, M. Levin, S. Blanche, A. Fischer, and J. Casanova. 1996. Interferon-γ-receptor deficiency in an infant with fatal Bacille Calmette-Guerin infection. N. Engl. J. Med. 335: 1956-1961.
43. Newport, M.J., C.M. Huxley, S. Huston, C.M. Hawrylowicz, B.A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949.
44. Green, S.J., C.A. Nacy, R.D. Schrieiber, D.L. Granger, R.M. Crawford, M.S. Meltzer, and A.H. Fortier. 1993. Neutralization of gamma interferon and tumor necrosis factor-alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun. 61:689-698.
45. Harty, J.T., and M.J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFNγ. Immunity. 3:109-117.